Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Antimicrob Agents Chemother
3 Eur Respir J
14 Int J Tuberc Lung Dis
6 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Antimicrob Agents Chemother

  1. YU JF, Xu JT, Yang SS, Gao MN, et al
    Decreased methylenetetrahydrofolate reductase activity leads to increased sensitivity to para-aminosalicylic acid in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Nov 15:AAC0146521. doi: 10.1128/AAC.01465.
    PubMed         Abstract available

    Eur Respir J

  2. GHODOUSI A, Rizvi AH, Khanzada FM, Akhtar N, et al
    In vivo Microevolution of Mycobacterium tuberculosis and transient emergence of atpE_Ala63Pro mutation during treatment in a pre-XDR TB patient.
    Eur Respir J. 2021 Nov 18. pii: 13993003.02102-2021.

  3. Tuberculosis and COVID-19 co-infection: description of the global cohort.
    Eur Respir J. 2021 Nov 11. pii: 13993003.02538-2021.
    PubMed         Abstract available

  4. XIN H, Cao X, Zhang H, Feng B, et al
    Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial.
    Eur Respir J. 2021 Nov 11. pii: 13993003.02359-2021.
    PubMed         Abstract available

    Int J Tuberc Lung Dis

  5. LUAN L, Fraisse P, Cordel H, Charlois C, et al
    Screening for active and latent TB among migrants in France.
    Int J Tuberc Lung Dis. 2021;25:903-910.
    PubMed         Abstract available

  6. WINCKLER JL, Schaaf HS, Draper HR, McIlleron H, et al
    Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB.
    Int J Tuberc Lung Dis. 2021;25:896-902.
    PubMed         Abstract available

  7. TAAFFE J, Croda J, Moultrie H, Silva DS, et al
    Advancing TB research using digitized programmatic data.
    Int J Tuberc Lung Dis. 2021;25:890-895.
    PubMed         Abstract available

  8. BOEREE MJ, Lange C, Thwaites G, Paton N, et al
    UNITE4TB: a new consortium for clinical drug and regimen development for TB.
    Int J Tuberc Lung Dis. 2021;25:886-889.

  9. OCHERETINA O, Brandao AP, Pang Y, Rodrigues C, et al
    Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2021;25:881-885.

  10. ALFFENAAR JC, Marais BJ, Thomas TA
    Is a high dose sufficient to achieve high isoniazid exposure in children affected by multidrug-resistant TB?
    Int J Tuberc Lung Dis. 2021;25:879-880.

  11. MURITHI W, Click ES, McCarthy KD, Okeyo E, et al
    Need for caution when interpreting Xpert((R)) MTB/RIF results for rifampin resistance among children.
    Int J Tuberc Lung Dis. 2021;25:911-916.
    PubMed         Abstract available

  12. STIEBER F, Howard J, Manissero D, Boyle J, et al
    Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis.
    Int J Tuberc Lung Dis. 2021;25:917-922.
    PubMed         Abstract available

  13. ANTONY S, Bodhanwala M, Shah I
    Clinical profile and outcomes of paediatric central nervous system tuberculomas.
    Int J Tuberc Lung Dis. 2021;25:953-955.

  14. FUKUSHIMA K, Akagi K, Kondoh A, Kubo T, et al
    Evaluation of QFT-Plus performance using blood samples stored at room temperature.
    Int J Tuberc Lung Dis. 2021;25:948-949.

  15. WOLTERS BA, Aartsma Y, Jansen K, van Hest R, et al
    Travel history and challenges of screening for latent TB infection in child asylum seekers.
    Int J Tuberc Lung Dis. 2021;25:945-947.

  16. CHRISTOPHER DJ, Coelho V, Ebby GS, Shankar D, et al
    Incremental yield of Xpert((R)) MTB/RIF Ultra over Xpert((R)) MTB/RIF in the diagnosis of extrapulmonary TB.
    Int J Tuberc Lung Dis. 2021;25:939-944.
    PubMed         Abstract available

  17. GATECHOMPOL S, Sophonphan J, Kerr SJ, Ubolyam S, et al
    Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV.
    Int J Tuberc Lung Dis. 2021;25:933-938.
    PubMed         Abstract available

  18. KASWA M, Minga G, Nkiere N, Mingiedi B, et al
    The economic burden of TB-affected households in DR Congo.
    Int J Tuberc Lung Dis. 2021;25:923-932.
    PubMed         Abstract available

    PLoS One

  19. KATHAMUTHU GR, Moideen K, Sridhar R, Baskaran D, et al
    Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis.
    PLoS One. 2021;16:e0253534.
    PubMed         Abstract available

  20. SULMAN S, Shahid S, Khaliq A, Ambreen A, et al
    Enhanced serodiagnostic potential of a fusion molecule consisting of Rv1793, Rv2628 and a truncated Rv2608 of Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0258389.
    PubMed         Abstract available

  21. AMBREEN A, Tahseen S, Wali A, Jamil M, et al
    Predictors of slow clinical response and extended treatment in patients with extra-pulmonary tuberculosis in Pakistan, A hospital-based prospective study.
    PLoS One. 2021;16:e0259801.
    PubMed         Abstract available

  22. PAPADOPOULOS AO, Ealand C, Gordhan BG, VanNieuwenhze M, et al
    Characterisation of a putative M23-domain containing protein in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0259181.
    PubMed         Abstract available

  23. MUFLIHAH H, Florido M, Lin LCW, Xia Y, et al
    Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection.
    PLoS One. 2021;16:e0259829.
    PubMed         Abstract available

  24. AYABINA DV, Gomes MGM, Nguyen NV, Vo L, et al
    The impact of active case finding on transmission dynamics of tuberculosis: A modelling study.
    PLoS One. 2021;16:e0257242.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  25. MONTGOMERY MG, Petri J, Spikes TE, Walker JE, et al
    Structure of the ATP synthase from Mycobacterium smegmatis provides targets for treating tuberculosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.